Keliomics

Keliomics is a pioneering biotech company that focuses on revolutionizing cancer treatment through its innovative Kelion Technology. This technology allows human tissues and tumors to be kept alive outside the human body, providing a unique platform for testing and improving the efficacy of current and next-generation cancer therapeutics. The company serves clinicians, researchers, and healthcare providers, operating in the cancer diagnostics and treatment market. Keliomics' business model revolves around its patented OncoScreen Technology, a clinical laboratory test that offers personalized solutions by identifying the most effective treatments for individual patients. The company generates revenue through the sale of these diagnostic tests and related services. By improving patient outcomes and reducing healthcare costs, Keliomics aims to transform patient care and the cancer diagnostic market.

Keywords: cancer treatment, Kelion Technology, human tissues, tumors, OncoScreen, diagnostics, personalized solutions, healthcare, biotech, patient outcomes.